126 related articles for article (PubMed ID: 21117707)
21. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity.
Winocur G; Greenwood CE; Piroli GG; Grillo CA; Reznikov LR; Reagan LP; McEwen BS
Behav Neurosci; 2005 Oct; 119(5):1389-95. PubMed ID: 16300445
[TBL] [Abstract][Full Text] [Related]
22. Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo.
Huhn R; Heinen A; Weber NC; Kerindongo RP; Oei GT; Hollmann MW; Schlack W; Preckel B
J Pharmacol Exp Ther; 2009 May; 329(2):600-7. PubMed ID: 19244549
[TBL] [Abstract][Full Text] [Related]
23. Differential adipose tissue inflammatory state in obese nondiabetic Zucker fatty rats compared to obese diabetic zucker diabetic fatty rats.
Miranville A; Herling AW; Biemer-Daub G; Voss MD
Horm Metab Res; 2012 Apr; 44(4):273-8. PubMed ID: 22399237
[TBL] [Abstract][Full Text] [Related]
24. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
[TBL] [Abstract][Full Text] [Related]
25. Changing pattern of gene expression is associated with ventricular myocyte dysfunction and altered mechanisms of Ca2+ signalling in young type 2 Zucker diabetic fatty rat heart.
Howarth FC; Qureshi MA; Hassan Z; Al Kury LT; Isaev D; Parekh K; Yammahi SR; Oz M; Adrian TE; Adeghate E
Exp Physiol; 2011 Mar; 96(3):325-37. PubMed ID: 21216827
[TBL] [Abstract][Full Text] [Related]
26. Quantitative histopathological assessment of retardation of islets of langerhans degeneration in rosiglitazone-dosed obese ZDF rats using combined insulin and collagens (I and III) immunohistochemistry with automated image analysis and statistical modeling.
Jones HB; Bigley AL; Pemberton J; Randall KJ
Toxicol Pathol; 2013; 41(3):425-44. PubMed ID: 23047688
[TBL] [Abstract][Full Text] [Related]
27. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
[TBL] [Abstract][Full Text] [Related]
28. Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.
Delghingaro-Augusto V; Nolan CJ; Gupta D; Jetton TL; Latour MG; Peshavaria M; Madiraju SR; Joly E; Peyot ML; Prentki M; Leahy J
Diabetologia; 2009 Jun; 52(6):1122-32. PubMed ID: 19294363
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats.
Topp BG; Atkinson LL; Finegood DT
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1730-5. PubMed ID: 17895283
[TBL] [Abstract][Full Text] [Related]
30. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
31. Anatomical versus functional beta-cell mass in experimental diabetes.
Kargar C; Ktorza A
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():43-53. PubMed ID: 18834432
[TBL] [Abstract][Full Text] [Related]
32. Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes.
Kreuz S; Schoelch C; Thomas L; Rist W; Rippmann JF; Neubauer H
Diabetes Metab Res Rev; 2009 Sep; 25(6):577-86. PubMed ID: 19618481
[TBL] [Abstract][Full Text] [Related]
33. Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.
Jones HB; Nugent D; Jenkins R
Int J Exp Pathol; 2010 Jun; 91(3):288-301. PubMed ID: 20384904
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats.
Wu L; Yang W; Jia X; Yang G; Duridanova D; Cao K; Wang R
Lab Invest; 2009 Jan; 89(1):59-67. PubMed ID: 19002107
[TBL] [Abstract][Full Text] [Related]
35. Effects of obesity and diabesity on heart rhythm in the Zucker rat.
Sultan A; Jacobson M; Adeghate E; Oulhaj A; Shafiullah M; Qureshi A; Howarth FC
Clin Exp Pharmacol Physiol; 2021 May; 48(5):735-747. PubMed ID: 33609055
[TBL] [Abstract][Full Text] [Related]
36. Elevation of circulating LOX-1 ligand levels in Zucker obese and diabetic rats.
Wakabayashi I; Shimomura T; Nakanishi M; Uchida K
Obes Res Clin Pract; 2015; 9(1):26-30. PubMed ID: 25434992
[TBL] [Abstract][Full Text] [Related]
37. Increased oxidative stress and mitochondrial dysfunction in zucker diabetic rat liver and brain.
Raza H; John A; Howarth FC
Cell Physiol Biochem; 2015; 35(3):1241-51. PubMed ID: 25766534
[TBL] [Abstract][Full Text] [Related]
38. Effects of Isoprenaline on ventricular myocyte shortening and Ca
Sultan A; Qureshi MA; Howarth FC
Eur J Pharmacol; 2022 Oct; 933():175263. PubMed ID: 36100128
[TBL] [Abstract][Full Text] [Related]
39. Melatonin reduces hepatic mitochondrial dysfunction in diabetic obese rats.
Agil A; El-Hammadi M; Jiménez-Aranda A; Tassi M; Abdo W; Fernández-Vázquez G; Reiter RJ
J Pineal Res; 2015 Aug; 59(1):70-9. PubMed ID: 25904243
[TBL] [Abstract][Full Text] [Related]
40. The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach.
Lu H; Yang Y; Allister EM; Wijesekara N; Wheeler MB
Mol Cell Proteomics; 2008 Aug; 7(8):1434-51. PubMed ID: 18448419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
